… and MEK inhibitors. Although many trials have compared BRAF and MEK inhibitor combination
… appropriate BRAF/MEK inhibitor combinations, we performed a meta-analysis of adverse …

… that combination therapy of BRAF and MEK inhibition achieved better curative effect and …
meta-analysis to evaluate the efficacy and safety between BRAF inhibition plus MEK inhibition …

… In conclusion, our current meta-analysis of five selected randomized controlled trials … MEK
inhibition had significant survival benefit over BRAF inhibition monotherapy. In addition, our …

… be partly due to the use of MEK inhibitors. In the subgroup analysis by type of MAPK inhibitor,
MEK inhibitors were the most effective MAPK inhibitor used as a single agent in ovarian …

… meta-analysis aims to evaluate the risk of ophthalmic adverse effects associated with MEK
inhibitors… to evaluate the efficacy and safety of MEK inhibitors. Overall risk of ophthalmic ad…

… meta-analysis of 5 randomized clinical trials including 2317 patients, treatment with BRAF
and MEK inhibitors … compared with treatment with BRAF inhibitor monotherapy. The risks of …

… Citation8 Hence, in this study, we have performed a meta-analysis to assess the therapeutic
… meta-analysis showed that the group treated with combination of BRAF and MEK inhibitors …

… and MEK inhibition are … meta-analysis was to appraise the differences in risk of selected
dermatological toxicities of combined BRAF and MEK inhibition versus the BRAF inhibition …

… Phase II/III clinical trials tested different MEK inhibitors (MEKis) in this complex malignancy,
with heterogenous results. Purpose of this systematic review and meta-analysis is to define …

… patients on the three MEK inhibitors (trametinib, selumetinib … were considered eligible for
the meta-analysis. The relative risk … : Our meta-analysis has demonstrated that MEK inhibitor-…